Financials
- Market Capitalization 1.56 B
- Employee 435
- Founded 2005
- CEO N/A
- Website www.xerispharma.com
- Headquarter Illinois, United States
- FIGI BBG012V1MG52
- Industry Biotechnologies
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
ratio cours/bénéfice
-79.2
ratio cours/chiffre d'affaires
4.13
Related tickers
| # | Nom | Prix | 24h % | 7 jours % | 1M % | 1 an % | Cap Boursière | 7 Derniers Jours | |
|---|---|---|---|---|---|---|---|---|---|
| 2148 | LBRX LB Pharmaceuticals Inc - Common Stock | 49.48 USD | +5.05% | +3.91% | +15.10% | +160.42% | 1.60 B USD | ||
| 2149 | AAPG Ascentage Pharma Group International - American Depository Shar | 17.00 USD | +4.74% | -7.71% | -0.58% | -32.00% | 1.59 B USD | ||
| 2162 | BCAX Bicara Therapeutics Inc. - Common Stock | 23.56 USD | +0.60% | -4.92% | -10.21% | +63.16% | 1.56 B USD | ||
| 2167 | INVA Innoviva, Inc. - Common Stock | 21.35 USD | +1.28% | +1.62% | +3.44% | +19.81% | 1.54 B USD |